Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
Genmab
Eli Lilly and Company
Case Comprehensive Cancer Center
University of California, Davis
Academic and Community Cancer Research United
University of Rochester
University of Giessen
Altor BioScience
City of Hope Medical Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
MEI Pharma, Inc.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Brown University
Alexion Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Universität des Saarlandes
Universität des Saarlandes
SecuraBio
CTI BioPharma
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
University of Arizona
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
University of Maryland, Baltimore
Alliance for Clinical Trials in Oncology
Swiss Cancer Institute
Gilead Sciences
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Gilead Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Beth Israel Deaconess Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute